Catalyst Wire Dossier Catalyst Wire Dossier

Gallium-68 Pentixafor

pentixafor (68Ga-labeled radiopharmaceutical)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gallium-68 Pentixafor, covering 2025-07-14 to 2025-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors [EARLY_Phase 1]

See pricing